Mechanisms of chromosomal rearrangements in solid tumors: The model of papillary thyroid carcinoma

Molecular and Cellular Endocrinology

Volumn 321, Issue 1, 2010, Pages 36-43

  Gandhi, Manoj ^a   Evdokimova, Viktoria ^a   Nikiforov, Yuri E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

DNA repair; Nuclear architecture; RET PTC; Thyroid cancer

Indexed keywords

B RAF KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 9; PROTEIN NTRK1; PROTEIN PATCHED; PROTEIN RET; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

CHROMOSOME REARRANGEMENT; DNA REPAIR; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE STRUCTURE; HUMAN; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; REVIEW; SOLID TUMOR; THYROID PAPILLARY CARCINOMA;

BASE SEQUENCE; CARCINOMA, PAPILLARY; CHROMOSOME ABERRATIONS; DNA REPAIR; GENE REARRANGEMENT; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; THYROID NEOPLASMS;

EID: 77950947395     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.013     Document Type: Review

References (102)

1. Ahmad A., Robinson A.R., Duensing A., van Drunen E., Beverloo H.B., Weisberg D.B., Hasty P., Hoeijmakers J.H., Niedernhofer L.J. ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol. Cell. Biol. 2008, 28:5082-5092.
2. Ahnesorg P., Smith P., Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006, 124:301-313.
3. Beimfohr C., Klugbauer S., Demidchik E.P., Lengfelder E., Rabes H.M. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident. Int. J. Cancer 1999, 80:842-847.
4. Bongarzone I., Butti M.G., Coronelli S., Borrello M.G., Santoro M., Mondellini P., Pilotti S., Fusco A., Della Porta G., Pierotti M.A. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res. 1994, 54:2979-2985.
5. Bongarzone I., Fugazzola L., Vigneri P., Mariani L., Mondellini P., Pacini F., Basolo F., Pinchera A., Pilotti S., Pierotti M.A. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1996, 81:2006-2009.
6. Bongarzone I., Butti M.G., Fugazzola L., Pacini F., Pinchera A., Vorontsova T.V., Demidchik E.P., Pierotti M.A. Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics 1997, 42:252-259.
7. Bounacer A., Wicker R., Caillou B., Cailleux A.F., Sarasin A., Schlumberger M., Suarez H.G. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997, 15:1263-1273.
8. Branco M.R., Pombo A. Intermingling of chromosome territories in interphase suggests role in translocations and transcription-dependent associations. PLoS Biol. 2006, 4:e138.
9. Brissett N.C., Doherty A.J. Repairing DNA double-strand breaks by the prokaryotic non-homologous end-joining pathway. Biochem. Soc. Trans. 2009, 37:539-545.
10. Bryant P.E., Riches A.C. Oncogenic transformation of murine C3H 10T1/2 cells resulting from DNA double-strand breaks induced by a restriction endonuclease. Br. J. Cancer 1989, 60:852-854.
11. Cardis E., Howe G., Ron E., Bebeshko V., Bogdanova T., Bouville A., Carr Z., Chumak V., Davis S., Demidchik Y., Drozdovitch V., Gentner N., Gudzenko N., Hatch M., Ivanov V., Jacob P., Kapitonova E., Kenigsberg Y., Kesminiene A., Kopecky K.J., Kryuchkov V., Loos A., Pinchera A., Reiners C., Repacholi M., Shibata Y., Shore R.E., Thomas G., Tirmarche M., Yamashita S., Zvonova I. Cancer consequences of the Chernobyl accident: 20 years on. J. Radiol. Prot. 2006, 26:127-140.
12. Caudill C.M., Zhu Z., Ciampi R., Stringer J.R., Nikiforov Y.E. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. J. Clin. Endocrinol. Metab. 2005, 90:2364-2369.
13. Chadwick K.H., Leenhouts H.P. The rejoining of DNA double-strand breaks and a model for the formation of chromosomal rearrangements. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1978, 33:517-529.
14. Ciampi R., Nikiforov Y.E. Alterations of the BRAF gene in thyroid tumors. Endocr. Pathol. 2005, 16:163-172.
15. Ciampi R., Knauf J.A., Kerler R., Gandhi M., Zhu Z., Nikiforova M.N., Rabes H.M., Fagin J.A., Nikiforov Y.E. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J. Clin. Invest. 2005, 115:94-101.
16. Ciampi R., Giordano T.J., Wikenheiser-Brokamp K., Koenig R.J., Nikiforov Y.E. HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma. Endocr. Relat. Cancer 2007, 14:445-452.
17. Cohen Y., Xing M., Mambo E., Guo Z., Wu G., Trink B., Beller U., Westra W.H., Ladenson P.W., Sidransky D. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 2003, 95:625-627.
18. Conrad R. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. Radiation Carcinogenesis: Epidemiology and Biological Significance 1984, 57-65. Raven Press, New York. J.J. Boice, J.J. Fraumeni (Eds.).
19. Cremer T., Cremer C. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2001, 2:292-301.
20. DuPraw E.J. Macromolecular organization of nuclei and chromosomes: a folded fibre model based on whole-mount electron microscopy. Nature 1965, 206:338-343.
21. Edwards A.A. Modelling radiation-induced chromosome aberrations. Int. J. Radiat. Biol. 2002, 78:551-558.
22. Elisei R., Romei C., Vorontsova T., Cosci B., Veremeychik V., Kuchinskaya E., Basolo F., Demidchik E.P., Miccoli P., Pinchera A., Pacini F. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J. Clin. Endocrinol. Metab. 2001, 86:3211-3216.
23. Fagin J.A. Genetics of papillary thyroid cancer initiation: implications for therapy. Trans. Am. Clin. Climatol. Assoc. 2005, 116:259-269. discussion 269-271.
24. Fenton C.L., Lukes Y., Nicholson D., Dinauer C.A., Francis G.L., Tuttle R.M. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J. Clin. Endocrinol. Metab. 2000, 85:1170-1175.
25. Fusco A., Grieco M., Santoro M., Berlingieri M.T., Pilotti S., Pierotti M.A., Della Porta G., Vecchio G. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 1987, 328:170-172.
26. Gandhi M., Medvedovic M., Stringer J.R., Nikiforov Y.E. Interphase chromosome folding determines spatial proximity of genes participating in carcinogenic RET/PTC rearrangements. Oncogene 2006, 25:2360-2366.
27. Gandhi M.S., Stringer J.R., Nikiforova M.N., Medvedovic M., Nikiforov Y.E. Gene position within chromosome territories correlates with their involvement in distinct rearrangement types in thyroid cancer cells. Genes Chromosomes Cancer 2009, 48:222-228.
28. Goodhead D.T. The initial physical damage produced by ionizing radiations. Int. J. Radiat. Biol. 1989, 56:623-634.
29. Goodhead D.T., Thacker J., Cox R. Weiss Lecture. Effects of radiations of different qualities on cells: molecular mechanisms of damage and repair. Int. J. Radiat. Biol. 1993, 63:543-556.
30. Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R., Bongarzone I., Pierotti M.A., Della Porta G., Fusco A., Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990, 60:557-563.
31. Gu W., Zhang F., Lupski J.R. Mechanisms for human genomic rearrangements. Pathogenetics 2008, 1:4.
32. Hamatani K., Eguchi H., Ito R., Mukai M., Takahashi K., Taga M., Imai K., Cologne J., Soda M., Arihiro K., Fujihara M., Abe K., Hayashi T., Nakashima M., Sekine I., Yasui W., Hayashi Y., Nakachi K. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Res. 2008, 68:7176-7182.
33. Hamilton T.E., van Belle G., LoGerfo J.P. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. JAMA 1987, 258:629-635.
34. Hlatky L., Sachs R.K., Vazquez M., Cornforth M.N. Radiation-induced chromosome aberrations: insights gained from biophysical modeling. Bioessays 2002, 24:714-723.
35. Huang L., Snyder A.R., Morgan W.F. Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene 2003, 22:5848-5854.
36. Hundahl S.A., Fleming I.D., Fremgen A.M., Menck H.R. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998, 83:2638-2648. (see comments).
37. Ito T., Seyama T., Iwamoto K.S., Hayashi T., Mizuno T., Tsuyama N., Dohi K., Nakamura N., Akiyama M. In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res. 1993, 53:2940-2943.
38. Katsura Y., Sasaki S., Sato M., Yamaoka K., Suzukawa K., Nagasawa T., Yokota J., Kohno T. Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo. DNA Repair (Amst.) 2007, 6:639-648.
39. Kazakov V.S., Demidchik E.P., Astakhova L.N. Thyroid cancer after Chernobyl. Nature 1992, 359:21.
40. Klugbauer S., Pfeiffer P., Gassenhuber H., Beimfohr C., Rabes H.M. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes. Genomics 2001, 73:149-160.
41. Kondo T., Ezzat S., Asa S.L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 2006, 6:292-306.
42. Kozubek S., Lukasova E., Ryznar L., Kozubek M., Liskova A., Govorun R.D., Krasavin E.A., Horneck G. Distribution of ABL and BCR genes in cell nuclei of normal and irradiated lymphocytes. Blood 1997, 89:4537-4545.
43. Kumagai A., Namba H., Saenko V.A., Ashizawa K., Ohtsuru A., Ito M., Ishikawa N., Sugino K., Ito K., Jeremiah S., Thomas G.A., Bogdanova T.I., Tronko M.D., Nagayasu T., Shibata Y., Yamashita S. Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004, 89:4280-4284.
44. Lee J.A., Carvalho C.M., Lupski J.R. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 2007, 131:1235-1247.
45. Li Z., Otevrel T., Gao Y., Cheng H.L., Seed B., Stamato T.D., Taccioli G.E., Alt F.W. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 1995, 83:1079-1089.
46. Lima J., Trovisco V., Soares P., Maximo V., Magalhaes J., Salvatore G., Santoro M., Bogdanova T., Tronko M., Abrosimov A., Jeremiah S., Thomas G., Williams D., Sobrinho-Simoes M. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004, 89:4267-4271.
47. Little J.B. Genomic instability and radiation. J. Radiol. Prot. 2003, 23:173-181.
48. Little J.B., Nagasawa H., Li G.C., Chen D.J. Involvement of the nonhomologous end joining DNA repair pathway in the bystander effect for chromosomal aberrations. Radiat. Res. 2003, 159:262-267.
49. Lobrich M., Rydberg B., Cooper P.K. Repair of X-ray-induced DNA double-strand breaks in specific Not I restriction fragments in human fibroblasts: joining of correct and incorrect ends. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:12050-12054.
50. Lodish H., Berk A., Zipursky L.S., Matsudaira P., Baltimore D., Darnell J. Molecular Cell Biology 1999, W.H. Freeman & Co., New York.
51. Ludwikow G., Xiao Y., Hoebe R.A., Franken N.A., Darroudi F., Stap J., Van Oven C.H., Van Noorden C.J., Aten J.A. Induction of chromosome aberrations in unirradiated chromatin after partial irradiation of a cell nucleus. Int. J. Radiat. Biol. 2002, 78:239-247.
52. Mansour W.Y., Schumacher S., Rosskopf R., Rhein T., Schmidt-Petersen F., Gatzemeier F., Haag F., Borgmann K., Willers H., Dahm-Daphi J. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res. 2008, 36:4088-4098.
53. Manuelidis L. A view of interphase chromosomes. Science 1990, 250:1533-1540.
54. Mari P.O., Florea B.I., Persengiev S.P., Verkaik N.S., Bruggenwirth H.T., Modesti M., Giglia-Mari G., Bezstarosti K., Demmers J.A., Luider T.M., Houtsmuller A.B., van Gent D.C. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18597-18602.
55. McVey M., Lee S.E. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet. 2008, 24:529-538.
56. Mizuno T., Kyoizumi S., Suzuki T., Iwamoto K.S., Seyama T. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis. Oncogene 1997, 15:1455-1460.
57. Mizuno T., Iwamoto K.S., Kyoizumi S., Nagamura H., Shinohara T., Koyama K., Seyama T., Hamatani K. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene 2000, 19:438-443.
58. Morgan W.F., Hartmann A., Limoli C.L., Nagar S., Ponnaiya B. Bystander effects in radiation-induced genomic instability. Mutat. Res. 2002, 504:91-100.
59. Nikiforov Y.E. RET/PTC rearrangement in thyroid tumors. Endocr. Pathol. 2002, 13:3-16.
60. Nikiforov Y.E. Radiation-induced thyroid cancer: what we have learned from Chernobyl. Endocr. Pathol. 2006, 17:307-317.
61. Nikiforov Y.E. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod. Pathol. 2008, 21(Suppl. 2):S37-S43.
62. Nikiforov Y.E. Papillary carcinoma. Diagnostic Pathology and Molecular Genetics of the Thyroid 2009, 160-213. Lippincott Williams & Wilkins, Baltimore. Y.E. Nikiforov (Ed.).
63. Nikiforov Y., Gnepp D.R. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 1994, 74:748-766.
64. Nikiforov Y.E., Nikiforova M.N., Gnepp D.R., Fagin J.A. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene 1996, 13:687-693.
65. Nikiforov Y.E., Rowland J.M., Bove K.E., Monforte-Munoz H., Fagin J.A. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997, 57:1690-1694.
66. Nikiforov Y.E., Koshoffer A., Nikiforova M., Stringer J., Fagin J.A. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas. Oncogene 1999, 18:6330-6334.
67. Nikiforova M.N., Stringer J.R., Blough R., Medvedovic M., Fagin J.A., Nikiforov Y.E. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 2000, 290:138-141.
68. Nikiforova M.N., Ciampi R., Salvatore G., Santoro M., Gandhi M., Knauf J.A., Thomas G.A., Jeremiah S., Bogdanova T.I., Tronko M.D., Fagin J.A., Nikiforov Y.E. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett. 2004, 209:1-6.
69. Odom O.W., Baek K.H., Dani R.N., Herrin D.L. Chlamydomonas chloroplasts can use short dispersed repeats and multiple pathways to repair a double-strand break in the genome. Plant J. 2008, 53:842-853.
70. Ostashevsky J.Y., Lange C.S. The 30nm chromatin fiber as a flexible polymer. J. Biomol. Struct. Dyn. 1994, 11:813-820.
71. Parker L.N., Belsky J.L., Yamamoto T., Kawamoto S., Keehn R.J. Thyroid carcinoma after exposure to atomic radiation. A continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971. Ann. Intern. Med. 1974, 80:600-604.
72. Paull T.T., Gellert M. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol. Cell 1998, 1:969-979.
73. Pfeiffer P., Goedecke W., Obe G. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 2000, 15:289-302.
74. Pierotti M.A., Bongarzone I., Borrello M.G., Mariani C., Miranda C., Sozzi G., Greco A. Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas. J. Endocrinol. Invest. 1995, 18:130-133.
75. Powell N., Jeremiah S., Morishita M., Dudley E., Bethel J., Bogdanova T., Tronko M., Thomas G. Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure. J. Pathol. 2005, 205:558-564.
76. Prentice R.L., Kato H., Yoshimoto K., Mason M. Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents. Natl. Cancer Inst. Monogr. 1982, 62:207-212.
77. Rabes H.M., Demidchik E.P., Sidorow J.D., Lengfelder E., Beimfohr C., Hoelzel D., Klugbauer S. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin. Cancer Res. 2000, 6:1093-1103.
78. Rattner J.B., Lin C.C. Radial loops and helical coils coexist in metaphase chromosomes. Cell 1985, 42:291-296.
79. Revell S.H. Proceedings: A speculation about observed differences in X-ray sensitivities of euploid and aneuploid mammalian cells. Br. J. Radiol. 1975, 48:416-417.
80. Roccato E., Bressan P., Sabatella G., Rumio C., Vizzotto L., Pierotti M.A., Greco A. Proximity of TPR and NTRK1 rearranging loci in human thyrocytes. Cancer Res. 2005, 65:2572-2576.
81. Roix J.J., McQueen P.G., Munson P.J., Parada L.A., Misteli T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nat. Genet. 2003, 34:287-291.
82. Ron E., Lubin J.H., Shore R.E., Mabuchi K., Modan B., Pottern L.M., Schneider A.B., Tucker M.A., Boice J.D. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 1995, 141:259-277.
83. Rothkamm K., Kuhne M., Jeggo P.A., Lobrich M. Radiation-induced genomic rearrangements formed by nonhomologous end-joining of DNA double-strand breaks. Cancer Res. 2001, 61:3886-3893.
84. Santoro M., Dathan N.A., Berlingieri M.T., Bongarzone I., Paulin C., Grieco M., Pierotti M.A., Vecchio G., Fusco A. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994, 9:509-516.
85. Santoro M., Thomas G.A., Vecchio G., Williams G.H., Fusco A., Chiappetta G., Pozcharskaya V., Bogdanova T.I., Demidchik E.P., Cherstvoy E.D., Voscoboinik L., Tronko N.D., Carss A., Bunnell H., Tonnachera M., Parma J., Dumont J.E., Keller G., Hofler H., Williams E.D. Gene rearrangement and Chernobyl related thyroid cancers. Br. J. Cancer 2000, 82:315-322.
86. Savage J.R. A brief survey of aberration origin theories. Mutat. Res. 1998, 404:139-147.
87. Smida J., Salassidis K., Hieber L., Zitzelsberger H., Kellerer A.M., Demidchik E.P., Negele T., Spelsberg F., Lengfelder E., Werner M., Bauchinger M. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int. J. Cancer 1999, 80:32-38.
88. Suchy B., Waldmann V., Klugbauer S., Rabes H.M. Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. Br. J. Cancer 1998, 77:952-955.
89. Takahashi K., Eguchi H., Arihiro K., Ito R., Koyama K., Soda M., Cologne J., Hayashi Y., Nakata Y., Nakachi K., Hamatani K. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose. Mol. Carcinog. 2007, 46:242-248.
90. Tallini G., Asa S.L. RET oncogene activation in papillary thyroid carcinoma. Adv. Anat. Pathol. 2001, 8:345-354.
91. Teo S.H., Jackson S.P. Identification of Saccharomyces cerevisiae DNA ligase IV: involvement in DNA double-strand break repair. EMBO J. 1997, 16:4788-4795.
92. Trujillo K.M., Yuan S.S., Lee E.Y., Sung P. Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95. J. Biol. Chem. 1998, 273:21447-21450.
93. Unger K., Zitzelsberger H., Salvatore G., Santoro M., Bogdanova T., Braselmann H., Kastner P., Zurnadzhy L., Tronko N., Hutzler P., Thomas G. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004, 89:4272-4279.
94. Ward J.F. DNA damage as the cause of ionizing radiation-induced gene activation. Radiat. Res. 1994, 138:S85-S88.
95. Windhofer F., Krause S., Hader C., Schulz W.A., Florl A.R. Distinctive differences in DNA double-strand break repair between normal urothelial and urothelial carcinoma cells. Mutat. Res. 2008, 638:56-65.
96. Winegar R.A., Lutze L.H., Rufer J.T., Morgan W.F. Spectrum of mutations produced by specific types of restriction enzyme-induced double-strand breaks. Mutagenesis 1992, 7:439-445.
97. Winship T., Rosvoll R.V. Cancer of the thyroid in children. Proc. Natl. Cancer Conf. 1970, 6:677-681.
98. Xing M. BRAF mutation in thyroid cancer. Endocr. Relat. Cancer 2005, 12:245-262.
99. Yates B.L., Morgan W.F. Nonhomologous DNA end rejoining in chromosomal aberration formation. Mutat. Res. 1993, 285:53-60.
100. Yokota H., van den Engh G., Hearst J.E., Sachs R.K., Trask B.J. Evidence for the organization of chromatin in megabase pair-sized loops arranged along a random walk path in the human G0/G1 interphase nucleus. J. Cell Biol. 1995, 130:1239-1249.
101. Zhu Z., Gandhi M., Nikiforova M.N., Fischer A.H., Nikiforov Y.E. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am. J. Clin. Pathol. 2003, 120:71-77.
102. Zhu Z., Ciampi R., Nikiforova M.N., Gandhi M., Nikiforov Y.E. Prevalence of Ret/Ptc rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J. Clin. Endocrinol. Metab. 2006.